Removal of Isoagglutinins from IVIG and Plasma Using Affinity Chromatography

June 12, 2017 Andy Davies

To download a copy of this poster please click on this link

About the Author

Andy Davies

An experienced Sales Director with over 25 years’ experience in the biotech and life sciences sectors, specialising in bioprocessing and bioseparation techniques with degree level Biochemistry from the University of West London. Having started my career working in a research and development laboratory, I have progressed into consultative sales roles for capital high-tech equipment and strategic account management, leveraging my lab experience for large pharmaceutical companies such as GE. I have been with Prometic Bioseparations (PBL) for over 5 years with responsibilities covering the global sales and marketing of its products and services. Since joining PBL, I have been instrumental in developing the product pipeline by successfully launching the ever-growing Evolve column range into PBL’s offering

Follow on Linkedin More Content by Andy Davies
Previous Article
Is it really cost effective to develop a custom affinity ligand as a capture step in your downstream process?
Is it really cost effective to develop a custom affinity ligand as a capture step in your downstream process?

We offer an extensive range of off-the-shelf Bioseparation products for the recovery and purification of bi...

Next Article
Evolve™ Process Column: Customer Evaluation
Evolve™ Process Column: Customer Evaluation

If you found this article useful, why not contact us to arrange a technical presentation?

Contact Us